VDR rs2228571: Understanding the TaqI Variant and Bone Health
The rs2228571 variant, commonly referred to as the TaqI polymorphism, is a genetic change located within the vitamin D receptor (VDR) gene. It is frequently studied for its potential influence on how the body processes vitamin D and its subsequent association with bone mineral density and skeletal health.
What each genotype means
Vitamin D receptor variant
This genotype is sometimes associated with different metabolic outcomes, such as variations in insulin sensitivity or polycystic ovary syndrome risk in specific study populations. Research on this variant is mixed and often ancestry-specific, so these findings may not apply to everyone. Please discuss any concerns regarding your health or vitamin D status with your clinician.
This genotype is generally less common than the T-allele containing genotypes in many populations, though frequencies vary significantly by ancestry.
Vitamin D receptor variant
This genotype represents a heterozygous state for the VDR TaqI polymorphism. Some studies suggest that individuals carrying the variant allele may show differences in their response to vitamin D supplementation, though the evidence remains limited and inconsistent across different groups. You should consult with your healthcare provider or a pharmacist regarding appropriate vitamin D intake for your specific health needs.
This is a common genotype found in a significant portion of the population across various ethnic groups.
Vitamin D receptor variant
This genotype has been investigated for potential links to metabolic traits, including obesity and bone mineral density, in various research studies. Because the evidence is limited and results often conflict between different populations, it is not possible to draw definitive conclusions about your personal health risk. Always discuss your vitamin D levels and any supplementation plans with your doctor.
This is a frequently observed genotype, particularly in European and other global populations where the T-allele is common.
What is the rs2228571 Variant?
The rs2228571 variant is a single nucleotide polymorphism (SNP) situated within the VDR gene, which is located on chromosome 12. In the scientific literature, this specific variant is widely recognized as the TaqI polymorphism. It is classified as a silent or synonymous variant, meaning that while it represents a change in the DNA sequence, it does not alter the primary amino acid sequence of the resulting vitamin D receptor protein. Instead, researchers have hypothesized that this variant may influence the stability of the VDR messenger RNA (mRNA). By potentially affecting how much mRNA is available or how long it persists, the variant could theoretically modulate the amount of receptor protein produced in various tissues throughout the body.
The Role of the VDR Gene
The VDR gene provides the essential instructions for creating the vitamin D receptor, a protein that acts as a nuclear receptor. When active vitamin D (calcitriol) binds to this receptor, the complex moves into the cell nucleus to regulate the expression of numerous genes. This process is fundamental to maintaining calcium homeostasis, which is critical for building and maintaining strong bones and teeth. Beyond skeletal health, the VDR pathway is involved in immune system regulation and cell growth. Because the receptor is a master regulator of gene expression, even subtle changes in its expression levels—potentially influenced by variants like rs2228571—are of significant interest to scientists investigating how genetic background might influence an individual's physiological response to vitamin D levels.
Research Associations and Evidence Strength
The association between rs2228571 and health outcomes is considered to have limited or mixed evidence. Many studies have investigated whether this variant correlates with bone mineral density (BMD) or the risk of osteoporosis, but results across different populations have been inconsistent. Some meta-analyses have suggested that the variant might play a role in modulating an individual's response to vitamin D supplementation, potentially influencing how effectively the body utilizes the nutrient to support bone health. However, because osteoporosis is a complex, polygenic condition influenced by many genes and environmental factors like diet and physical activity, it is difficult to isolate the specific impact of a single SNP. Consequently, while the TaqI variant remains a popular subject in candidate gene studies, it is not currently used as a definitive clinical marker for predicting bone disease.
Interpreting Your Genetic Information
It is important to understand that having a specific genotype for rs2228571 does not provide a diagnosis or a guaranteed health outcome. Genetic variants are only one piece of a much larger puzzle that includes your lifestyle, nutrition, and overall medical history. If you are concerned about your bone health or your vitamin D levels, the most effective approach is to consult with a healthcare professional. They can order appropriate blood tests to measure your actual vitamin D status and assess your bone density through clinical imaging. Never use genetic information to make decisions about supplements or medications without first discussing them with your doctor or a licensed pharmacist, as they can provide guidance tailored to your specific health needs and current medical regimen.
How common is this variant?
The rs2228571 variant is common, with a minor allele frequency (MAF) typically ranging between 0.35 and 0.45 in European populations. Frequency distributions can vary significantly across different global ancestries.
Frequently asked questions
Is rs2228571 the same as the TaqI polymorphism?
Yes, rs2228571 is the official identifier for the variant commonly referred to as the TaqI polymorphism in the VDR gene.
Does this variant cause osteoporosis?
No, this variant does not cause osteoporosis. While some studies have explored its association with bone mineral density, osteoporosis is a complex disease influenced by many genetic and environmental factors.
Should I take more vitamin D if I have a certain genotype?
You should not change your supplement intake based on a genetic test result. Always consult your doctor or pharmacist to determine the appropriate vitamin D levels for your specific health needs.
Where can I find more information on VDR variants?
You can find reliable information on the VDR gene and its variants through resources like MedlinePlus Genetics, the NCBI Gene database, and the GWAS Catalog.
Sources & further reading
Educational information only, last refreshed 9/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2228571?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in VDR
Variant in the promoter region (Cdx2 site) of the vitamin D receptor gene associated with altered intestinal calcium absorption and bone mineral density.
This variant in the Vitamin D receptor gene is associated with susceptibility to Type 1 Diabetes and autoimmune thyroid disease.
Promoter polymorphism (Cdx2) in the VDR gene associated with bone mineral density and vitamin D metabolism.
Known as the TaqI polymorphism, this variant is located in the 3' UTR of the VDR gene and is associated with altered mRNA stability, influencing vitamin D signaling, cancer cachexia susceptibility, and gastric cancer risk.
Variant in the VDR promoter (Cdx-2 binding site) associated with bone mineral density and calcium absorption efficiency.
The Cdx2 polymorphism in the VDR promoter influences vitamin D receptor expression and is associated with bone mineral density.